Maravai LifeSciences Holdings, Inc. revenue breakdown overview

Maravai LifeSciences Holdings, Inc. revenue for the last year amounted to 288.94 M USD, the most of which — 224.77 M USD — came from its highest performing source at the moment, Nucleic Acid Production, the year earlier bringing 813.08 M USD. The greatest contribution to the revenue figure was made by North America — last year it brought Maravai LifeSciences Holdings, Inc. 141.06 M USD, and the year before that — 339.47 M USD.